A multi-center study of HRC-101 for the treatment of the patients with moderate refractory ulcerative colitis

A multi-center study of HRC-101 for the treatment of the patients with moderate refractory ulcerative colitis - A clinical study of HRC-101 for the treatment of ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010430

Enrollment

Registered

2013-04-08

Start date

2013-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

Patients treated with HRC-101

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with refractory ulcrative colitis

Exclusion criteria

Exclusion criteria: 1.Patients with serious cardiovascular disease 2.Patients with a history of hypersensitivity for anticoagulants 3.Patients with hypercoagulability 4.Patients after colectomy 5.Patients with infeciton disease 6.Other patients who were considered ineligible for the study by the investigator

Design outcomes

Primary

Measure	Time frame
Clinical response rate	—

Countries

Japan

Contacts

Public ContactHiroyuki Doi

Toray Industries,Inc. Medical Devices Clinical Research Dept.

Hiroyuki_Doi@nts.toray.co.jp047-350-6491

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026